TNF and inflammatory bowel disease: Whether these phenomena—described in animal models and humans—are mediated by the direct interaction of anti-TNF-α molecules with tmTNF on immune cells, as suggested in the case of parenterally administered TNF-α-blocking agents in IBD, is to be established.